K Park1, M Steffes, D-H Lee, J H Himes, D R Jacobs. 1. Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, 1300 South 2nd Street, Suite 300, Minneapolis, MN 55454, USA.
Abstract
AIMS/HYPOTHESIS: We examined the cross-sectional and longitudinal relationships between C-reactive protein (CRP), a marker of low-grade inflammation, and insulin resistance and whether the association was independent of obesity and oxidative stress. METHODS: CRP and insulin resistance (homeostasis model assessment of insulin resistance [HOMA-IR]) data were obtained in a population-based, prospective observational study, Coronary Artery Risk Development in Young Adults (CARDIA), during 1992-2006. RESULTS: CRP showed a significant positive association with insulin resistance, both cross-sectionally and longitudinally (5 year follow-up). The estimated increment in HOMA-IR was 0.34 log(e)(pmol/l x [mmol/l]/156.25) (p value for trend <0.0001) in the highest vs lowest CRP quartiles in cross-sectional analysis, whereas the corresponding estimate was 0.12 (p trend <0.0001) in the highest vs lowest CRP quartiles longitudinally over 5 years. The gradient of HOMA-IR across CRP was attenuated but remained statistically significant after controlling for body fat measurements (0.06 in the highest vs lowest CRP in both cross-sectional [p value for trend = 0.001] and longitudinal analyses [p value for trend = 0.01]), and was little changed by further adjustment for oxidative stress markers (F(2)-isoprostanes and oxidised LDL). There were consistent increments in the levels of HOMA-IR with increasing concentrations of CRP over time. In contrast, higher HOMA-IR did not predict future increases in CRP. Findings were similar using fibrinogen as the predictor variable. CONCLUSIONS/ INTERPRETATION: Although a substantial portion of this association was explained by obesity, CRP was independently related to concurrent and future insulin resistance.
AIMS/HYPOTHESIS: We examined the cross-sectional and longitudinal relationships between C-reactive protein (CRP), a marker of low-grade inflammation, and insulin resistance and whether the association was independent of obesity and oxidative stress. METHODS:CRP and insulin resistance (homeostasis model assessment of insulin resistance [HOMA-IR]) data were obtained in a population-based, prospective observational study, Coronary Artery Risk Development in Young Adults (CARDIA), during 1992-2006. RESULTS:CRP showed a significant positive association with insulin resistance, both cross-sectionally and longitudinally (5 year follow-up). The estimated increment in HOMA-IR was 0.34 log(e)(pmol/l x [mmol/l]/156.25) (p value for trend <0.0001) in the highest vs lowest CRP quartiles in cross-sectional analysis, whereas the corresponding estimate was 0.12 (p trend <0.0001) in the highest vs lowest CRP quartiles longitudinally over 5 years. The gradient of HOMA-IR across CRP was attenuated but remained statistically significant after controlling for body fat measurements (0.06 in the highest vs lowest CRP in both cross-sectional [p value for trend = 0.001] and longitudinal analyses [p value for trend = 0.01]), and was little changed by further adjustment for oxidative stress markers (F(2)-isoprostanes and oxidised LDL). There were consistent increments in the levels of HOMA-IR with increasing concentrations of CRP over time. In contrast, higher HOMA-IR did not predict future increases in CRP. Findings were similar using fibrinogen as the predictor variable. CONCLUSIONS/ INTERPRETATION: Although a substantial portion of this association was explained by obesity, CRP was independently related to concurrent and future insulin resistance.
Authors: Anne G Niehoff; Timon W van Haeften; N Charlotte Onland-Moret; Clara C Elbers; Cisca Wijmenga; Yvonne T van der Schouw Journal: Diabetes Care Date: 2007-03-19 Impact factor: 19.112
Authors: Jeppe Zacho; Anne Tybjaerg-Hansen; Jan Skov Jensen; Peer Grande; Henrik Sillesen; Børge G Nordestgaard Journal: N Engl J Med Date: 2008-10-30 Impact factor: 91.245
Authors: Bharat Thyagarajan; David R Jacobs; George G Apostol; Lewis J Smith; Cora E Lewis; O Dale Williams Journal: Int J Epidemiol Date: 2006-03-22 Impact factor: 7.196
Authors: Teresa Tamayo; David R Jacobs; Klaus Strassburger; Guido Giani; Teresa E Seeman; Karen Matthews; Jeffrey M Roseman; Wolfgang Rathmann Journal: Eur J Epidemiol Date: 2012-05-08 Impact factor: 8.082
Authors: Birgit Klüppelholz; Barbara Thorand; Wolfgang Koenig; Tonia de Las Heras Gala; Christa Meisinger; Cornelia Huth; Guido Giani; Paul W Franks; Michael Roden; Wolfgang Rathmann; Annette Peters; Christian Herder Journal: Diabetologia Date: 2015-07-09 Impact factor: 10.122
Authors: Raymond C-S Seet; Chung-Yung J Lee; Erle C H Lim; Amy M L Quek; Shan-Hong Huang; Chin-Meng Khoo; Barry Halliwell Journal: Diabetes Care Date: 2010-02-25 Impact factor: 19.112
Authors: Ryan T Demmer; Alexander Breskin; Michael Rosenbaum; Aleksandra Zuk; Charles LeDuc; Rudolph Leibel; Bruce Paster; Moïse Desvarieux; David R Jacobs; Panos N Papapanou Journal: J Clin Periodontol Date: 2017-01-27 Impact factor: 8.728
Authors: M Guzmán-Fulgencio; J Berenguer; M García-Álvarez; D Micheloud; J C López; J Cosín; I Fernández de Castro; P Catalán; P Miralles; S Resino Journal: Eur J Clin Microbiol Infect Dis Date: 2011-03-26 Impact factor: 3.267
Authors: Michael S Boger; Aihua Bian; Ayumi Shintani; Ginger L Milne; Jason D Morrow; Husamettin Erdem; Valerie Mitchell; David W Haas; Todd Hulgan Journal: Antivir Ther Date: 2011-12-14
Authors: Ryan T Demmer; Sara Gelb; Shakira F Suglia; Katherine M Keyes; Allison E Aiello; Paolo C Colombo; Sandro Galea; Monica Uddin; Karestan C Koenen; Laura D Kubzansky Journal: Psychosom Med Date: 2015-05 Impact factor: 4.312
Authors: Pia Deichgræber; Daniel R Witte; Holger J Møller; Mette V Skriver; Bjørn Richelsen; Marit E Jørgensen; Nanna B Johansen; Annelli Sandbæk Journal: Diabetologia Date: 2016-08-19 Impact factor: 10.122